Pinto Cláudia A, Fonseca Bruno M, Sá Susana I
Unit of Anatomy, Department of Biomedicine, Faculty of Medicine, University of Porto, Al Professor Hernani Monteiro, 4200-319 Porto, Portugal.
UCIBIO, REQUIMTE, Laboratory of Biochemistry, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira nº. 228, 4050-313 Porto, Portugal.
Heliyon. 2022 Dec 17;8(12):e12362. doi: 10.1016/j.heliyon.2022.e12362. eCollection 2022 Dec.
The medial preoptic (MPN) and the ventromedial hypothalamic nuclei (VMN) modulate the estrogen receptor (ER)-dependent female sexual behavior, a response that is inhibited by tamoxifen (TAM), a modulator of the steroid receptor activation. With the objective to assess TAM action in the brain areas involved in the modulation sexual cues, an animal model on long-term TAM therapy to intact female rats, was used to mimic the 5-year prophylactic TAM therapy offered to women at higher risk of breast cancer. After three months treatment, female sexual behavior with a stud male rat was evaluated. Upon sacrifice, the brains were removed and the MPN and the ventrolateral division of the VMN were screened for the effects of TAM in the expression of ERα, ERβ and progesterone receptor. Results show that TAM inhibited the receptive component of the female sexual behavior. Even though TAM decreased estrogen and progesterone levels to values similar to the ones of estrous and diestrus rats, the biochemical data failed to demonstrate such possible causation for the behavioral response. In fact, TAM administration induced a constant low level of ovarian hormones that changed the pattern of ER and PR expression as well as receptor co-expression in the brain areas regulating the behavioral response, dissimilar to the ones seen in the cycle phases with the same low hormone levels. Nevertheless, present data suggests that by affecting ER- and/or PR-dependent mechanisms, TAM may modulate the hypothalamus, a region known to participate in several social behaviors.
内侧视前区(MPN)和下丘脑腹内侧核(VMN)调节雌激素受体(ER)依赖性的雌性性行为,这种反应会被他莫昔芬(TAM)抑制,他莫昔芬是一种类固醇受体激活调节剂。为了评估TAM在参与调节性线索的脑区中的作用,使用了一种对完整雌性大鼠进行长期TAM治疗的动物模型,以模拟为乳腺癌高风险女性提供的为期5年的预防性TAM治疗。经过三个月的治疗后,评估了与雄性种鼠的雌性性行为。处死后,取出大脑,筛选MPN和VMN的腹外侧部分中TAM对ERα、ERβ和孕激素受体表达的影响。结果表明,TAM抑制了雌性性行为的接受成分。尽管TAM将雌激素和孕激素水平降低到与发情期和动情后期大鼠相似的值,但生化数据未能证明这种行为反应的可能因果关系。事实上,给予TAM会诱导卵巢激素持续处于低水平,这改变了调节行为反应的脑区中ER和PR的表达模式以及受体共表达,这与在相同低激素水平的周期阶段中看到的情况不同。然而,目前的数据表明,通过影响ER和/或PR依赖性机制,TAM可能会调节下丘脑,下丘脑是一个已知参与多种社会行为的区域。